Transformed Sandoz Is Important Part Of Novartis

 
• By Aidan Fry
  
Novartis
Novartis chief Vas Narasimhan sees sandoz as an 'important part' of the swiss group • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products